Progression Patterns and Post-Progression Survival in Recurred Intrahepatic Cholangiocarcinoma Patients: A Novel Prognostic Nomogram Based on Multicenter Cohorts

被引:2
|
作者
Zhao, Chongyu [1 ]
He, Chaobin [1 ]
Lu, Jiawei [2 ]
Huang, Xin [1 ]
Chen, Cheng [3 ]
Lin, Xiaojun [1 ]
机构
[1] Sun Yat sen Univ, Dept Pancreatobiliary Surg, State Key Lab Oncol South China, Collaborat Innovat Centerfor Canc Med Canc Ctr, Guangzhou, Peoples R China
[2] Dalian Med Univ, Dept Oncol, Hosp 2, Dalian, Peoples R China
[3] Dalian MedicalUnivers, Dept Cardiol, Affiliated Hosp 1, Dalian, Peoples R China
来源
FRONTIERS IN ONCOLOGY | 2022年 / 12卷
基金
中国国家自然科学基金;
关键词
intrahepatic cholangiocarcinoma; post-progression survival; recurrence; prognosis; nomogram; HEPATOCELLULAR-CARCINOMA; MANAGEMENT; RESECTION; DIAGNOSIS; PREDICT;
D O I
10.3389/fonc.2022.832038
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BackgroundThe post-progression survival (PPS) of recurred intrahepatic cholangiocarcinoma (iCCA) patients relates to the characteristics of tumor progression. Moreover, the prediction model of PPS in those patients has not been well established. This study aimed at developing a novel nomogram for predicting PPS in recurred iCCA patients. MethodClinical characteristics were retrospectively collected in 396 patients diagnosed with iCCA from cohorts of Sun Yat-sen University Cancer Center (SYSUCC) and the First Hospital of Dalian Medical University (FHDMU). The PPS in patients with different progression patterns was investigated. The nomogram of PPS was established with the Cox regression model in the primary cohort. Then the nomogram was verified in the external validation cohort. ResultsLiver progression was the commonest pattern (42.08%) in recurred iCCA patients, while patients with local LN progression had significantly better PPS than those with other patterns. The independent prognostic factors comprised elevated CEA levels, tumor differentiation, N stage 8th, adjuvant therapy, Local LN metastasis, Liver Metastasis only, and Multiple Metastasis. The nomogram constructed on these factors achieved satisfied C-indexes of 0.794 (95% CI 0.769-0.828) and 0.827 (0.779-0.876) for the training and validation cohorts, respectively. These values were significantly higher than those of the 8th TNM stage system (all p < 0.001). The recurred iCCA patients could be precisely classified into high- and low-risk groups according to the cutoff point of this nomogram (p < 0.01). ConclusionThe investigation of progression patterns and the development of this nomogram can offer new evidence to precisely postoperative and post-progression management of iCCA patients.
引用
收藏
页数:12
相关论文
共 50 条
  • [21] Progression-free survival and post-progression survival in patients with advanced gastric cancer treated with first-line chemotherapy
    Kohei Shitara
    Keitaro Matsuo
    Kei Muro
    Toshihiko Doi
    Atsushi Ohtsu
    Journal of Cancer Research and Clinical Oncology, 2013, 139 : 1383 - 1389
  • [22] The impact of post-progression survival on overall survival of patients with advanced hepatocellular carcinoma treated by sorafenib therapy
    Terashima, Takeshi
    Yamashita, Tatsuya
    Takata, Noboru
    Nakagawa, Hidetoshi
    Arai, Kuniaki
    Kagaya, Takashi
    Mizukoshi, Eishiro
    Honda, Masao
    Kaneko, Shuichi
    HEPATOLOGY, 2013, 58 : 1221A - 1221A
  • [23] Progression-free survival, post-progression survival, and tumor response as surrogate markers for overall survival in patients with extensive small cell lung cancer
    Imai, Hisao
    Mori, Keita
    Wakuda, Kazushige
    Ono, Akira
    Akamatsu, Hiroaki
    Shukuya, Takehito
    Taira, Tetsuhiko
    Kenmotsu, Hirotsugu
    Naito, Tateaki
    Kaira, Kyoichi
    Murakami, Haruyasu
    Endo, Masahiro
    Nakajima, Takashi
    Yamamoto, Nobuyuki
    Takahashi, Toshiaki
    ANNALS OF THORACIC MEDICINE, 2015, 10 (01) : 61 - 66
  • [24] Novel Prognostic Nomogram to Predict Progression-Free Survival of Patients with Hepatocellular Carcinoma After Transarterial Chemoembolization
    Xi, Dong
    Xu, Mengying
    Han, Meiwen
    Guan, Qianting
    Guo, Qinghao
    Yan, Fangfei
    Yao, Junxia
    Ning, Qin
    JOURNAL OF HEPATOCELLULAR CARCINOMA, 2023, 10 : 909 - 920
  • [25] Modeling post-progression survival in patients with HER2-positive metastatic gastric cancer
    Chae, Dong Woo
    Kim, Joo Hoon
    Kim, Chan
    Chon, Hong Jae
    Lee, Choong-kun
    Kim, Hyo Song
    Jung, Minkyu
    Chung, Hyun Cheol
    Rha, Sun Young
    Park, Kyung Soo
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [26] Clinical Impact of Post-Progression Survival for Overall Survival in Patients with Sensitive Relapse of Small Cell Lung Cancer
    Miura, Yosuke
    Imai, Hisao
    Yoshino, Reiko
    Fujimoto, Sakae
    Kaira, Kyoichi
    Sunaga, Noriaki
    Tomizawa, Yoshio
    Minato, Koichi
    Hisada, Takeshi
    Saito, Ryusei
    Yamada, Masanobu
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S741 - S742
  • [27] The effect of post-progression survival on overall survival among patients with sensitive relapse of small cell lung cancer
    Yosuke Miura
    Hisao Imai
    Reiko Sakurai
    Kyoichi Kaira
    Noriaki Sunaga
    Koichi Minato
    Ryusei Saito
    Takeshi Hisada
    Medical Oncology, 2018, 35
  • [28] Pattern of care and post-progression survival in recurrent GBM after TMZ-based chemoradiation
    Kim, D.
    Lee, J. H.
    Yoon, H. I.
    Kim, N.
    Lim, D. H.
    Song, J. H.
    Wee, C. W.
    Kim, I. A.
    RADIOTHERAPY AND ONCOLOGY, 2023, 182 : S902 - S902
  • [29] Prognostic nomogram for cancer-specific survival in patients with intrahepatic cholangiocarcinoma after hepatectomy: A population study of 919 patients
    Huang, Gaobo
    Song, Weilun
    Zhang, Yanchao
    Ren, Bingyi
    Lv, Yi
    Liu, Kang
    FRONTIERS IN SURGERY, 2023, 9
  • [30] Immune Checkpoint Inhibitors Affect Post-Progression Survival of Specific Patient Subgroups With Advanced Hepatocellular Carcinoma: A Study Cohorts' Analysis
    Colloca, Giuseppe A.
    Venturino, Antonella
    JOURNAL OF DIGESTIVE DISEASES, 2024, 25 (11-12) : 655 - 663